Rocket Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Rocket Pharmaceuticals, Inc. (RCKT) had Operating Leases, Future Minimum Payments, Due in Two Years of $2.53 million as of 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-03-06
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.53M.
- 2019-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $2.40M.
- 2019-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $1.97M.
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $1.97M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2019-12-31 | $2.53M 10-K · filed 2020-03-06 |
| 2019-09-30 | $2.40M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.97M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.97M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.95M 10-K · filed 2019-03-08 |
| 2018-09-30 | $1.12M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $771.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $874.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $421.00K 10-K · filed 2018-03-07 |
| 2017-09-30 | $411.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $411.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $411.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $411.00K 10-K · filed 2017-03-16 |
| 2016-09-30 | $402.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $402.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $402.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $289.00K 10-K · filed 2016-03-23 |
| 2015-09-30 | $209.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |